General Discussions
Recommending that patients “get up and move” can be the best advice for health care professionals to offer patients when assisting in their recovery to improve their overall wellness an...
Clostridium difficile (C. diff) is a gram-positive, spore-forming bacterium noted to be the leading cause of hospital-acquired diarrhea in patients with cancer undergoing chemotherapy.1 A...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has scheduled a date to review data supporting the biologics license application (BLA) for remestemcel-L (Ryoncil) as a treatment for child...
I love introducing new nurses to the joy of oncology nursing. The process is gratifying, stressful, and brings much happiness and meaning to my work. However, this year is difficult for everyone in...
The field of HER2-positive breast cancer has expanded immensely in recent years, with the FDA approvals of trastuzumab (Herceptin), pertuzumab (Perjeta), neratinib (Nerlynx), and ado-trastuzumab em...
Nancy Corbitt, BSN, RN, OCN, CRNI, University of Maryland Marlene and Stewart Greenebaum Cancer Center discusses the resources available for nurses from the Aplastic Anemia and MDS International ...
Transcript: Kate Jeffers, PharmD: At our facility, we have a multidisciplinary team that interacts with these patients. So our oncologist or attending obviously does the initial prescribin...
Healthcare providers and citizens alike are navigating uncharted territories when it comes to the novel coronavirus/COVID-19. “It’s an important part of the discussion to recognize tha...
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.